Correction to: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance (Oncogene, (2009), 28, 6, (832-842), 10.1038/onc.2008.439);Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance

Oncogene

Volumn 28, Issue 6, 2009, Pages 832-842

  Veuger, S J ^a   Hunter, J E ^a   Durkacz, B W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Ionizing radiation; NF B; PARP 1

Indexed keywords

AG 14361; CASPASE 3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PROTEIN P50; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG POTENTIATION; DRUG SENSITIZATION; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; REGULATORY MECHANISM; REPORTER GENE;

EID: 60149100173     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-023-02605-w     Document Type: Erratum

References (52)

1. Althaus FR, Hofferer L, Kleczkowska HE, Malanga M, Naegeli H, Panzeter PL et al. (1994). Histone shuttling by poly ADP-ribosylation. Mol Cell Biochem 138: 53-59.
2. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, Rosier RN. (2000). Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 60: 6557-6562.
3. Barkett M, Gilmore TD. (1999). Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18: 6910-6924.
4. Bassères DS, Baldwin AS. (2006). Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830.
5. Beg AA, Baltimore D. (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784.
6. Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. (2001). The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA 98: 10386-10391.
7. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB et al. (2004). NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101: 10137-10142.
8. Brach M, Hass R, Sherman M, Gunji H, Weichselbaum R, Kufe D. (1991). Ionizing radiation induces expression and binding activity of the nuclear factor kB. J Clin Invest 88: 691-695.
9. Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canan-Koch S et al. (2004). Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J Natl Cancer Inst 96: 56-67.
10. Cao Y, Karin M. (2003). NF-kappaB in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8: 215-223.
11. Cardoso SM, Oliveira CR. (2003). Inhibition of NF-kB renders cells more vulnerable to apoptosis induced by amyloid beta peptides. Free Radic Res 37: 967-973.
12. Carrillo A, Monreal Y, Ramirez P, Marin L, Parrilla P, Oliver FJ et al. (2004). Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleic Acids Res 32: 757-766.
13. Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B. (2004). PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys 58: 410-419.
14. Chang WJ, Alvarez-Gonzalez R. (2001). The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J Biol Chem 276: 47664-47670.
15. Chiarugi A, Moskowitz MA. (2003). Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 85: 306-317.
16. Concin N, Zeillinger C, Tong D, Stimpfl M, Konig M, Printz D et al. (2003). Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Breast Cancer Res Treat 79: 37-46.
17. Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA. (2003). Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22: 5813-5827.
18. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG et al. (2004). Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279: 5405-5412.
19. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Read GC. (1999). Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 18: 5242-5251.
20. Ferreira C, van der Valk P, Span S, Jonker J, Postmus P, Kruyt F et al. (2001). Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann Oncol 12: 799-805.
21. Ghosh S, Karin M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl): S81-S96.
22. Grube K, Kupper JH, Burkle A. (1991). Direct stimulation of poly(ADP ribose) polymerase in permeabilized cells by double-stranded DNA oligomers. Anal Biochem 193: 236-239.
23. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. (2001). The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 276: 45588-45597.
24. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H et al. (2005). Acetylation of PARP-1 by p300/CBP regulates coactivation of NF-kappa B-dependent transcription. J Biol Chem 280: 40450-40464.
25. Hassa PO, Hottiger MO. (1999). A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. J Biol Chem 380: 953-959.
26. Holcik N, Gibson H, Korneluk RG. (2001). XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6: 253.
27. Jung M, Dritschilo A. (2001). NF-kappa B signaling pathway as a target for human tumor radiosensitization. Semin Radiat Oncol 11: 346-351.
28. Kraus W, Lis J. (2003). PARP goes transcription. Cell 113: 677-683.
29. Martin-Oliva D, Aguilar-Quesada R, O'valle F, Munoz-Gamez JA, Martinez-Romero R, Garcia Del Moral R et al. (2006). Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res 66: 5744-5756.
30. Nakajima H, Nagaso H, Kakui N, Ishikawa M, Hiranuma T, Hoshiko S. (2004). Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells. J Biol Chem 279: 42774-42786.
31. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW. (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639.
32. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S et al. (1999). Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18: 4446-4454.
33. Pande V, Ramos MJ. (2005). NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem 12: 357-374.
34. Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S et al. (2000). Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene 19: 4159-4169.
35. Penolazzi L, Lambertini E, Borgatti M. (2003). Decoy oligodeoxynucleotides targeting NFkB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 66: 1189-1198.
36. Perkins ND. (2006). Good cop, bad cop: the different faces of NF-kappaB. Oncogene 25: 6717-6730.
37. Pratt MA, Bishop TE, White D, Yasvinski G, Menard M, Niu MY et al. (2003). Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence. Mol Cell Biol 23: 6887-6900.
38. Raju U, Gumin GJ, Noel F, Tofilon PJ. (1998). IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells. Int J Radiat Biol 74: 617-624.
39. Rayet B, Gelinas C. (1999). Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938-6947.
40. Russo SM, Tepper JE, Baldwin Jr AS, Liu R, Adams J, Elliott P et al. (2001). Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys 50: 183-193.
41. Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, Salvesen GS. (2005). XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J 24: 645-655.
42. Skalitzky DJ, Marakovits JT, Maegley KA, Ekker A, Yu XH, Hostomsky Z et al. (2003). Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem 46: 210-213.
43. Smith S. (2001). The world according to PARP. Trends Biochem Sci 26: 174-179.
44. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM et al. (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952-2960.
45. Veuger SJ, Curtin NJ, Richardson CJ, Smith GC, Durkacz BW. (2003). Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res 63: 6008-6015.
46. Wang CY, Mayo MW, Baldwin Jr AS. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787.
47. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS. (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
48. Webster GA, Perkins ND. (1999). Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 19: 3485-3495.
49. Wu JT, Kral JG. (2005). The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 123: 158-169.
50. Xiao CW, Ash K, Tsang BK. (2001). Nuclear factor-kappaB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor alpha-induced apoptosis. Endocrinology 142: 557-563.
51. Yang L, Cao Z, Yan H, Wood W. (2003). Coexistence of high levels of apoptotic signalling and inhibitor of apoptosis proteins in human tumour cells: Implications for cancer specific therapy. Cancer Research 63: 6815-6824.
52. Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, Eppenberger U et al. (2005). Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 37: 1130-1144.